![](https://endpts.com/wp-content/uploads/2023/08/AP23179572573513-scaled.jpg)
Pascal Soriot, AstraZeneca CEO (Justin Tallis/Press Association via AP Images)
AstraZeneca makes $1B deal for Gracell and its cell therapies, adding to China ties
AstraZeneca will pay $1 billion to buy China-US cell therapy company Gracell Biotechnologies, adding to a rush of deals that have been announced at the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.